Unpacking the Mounjaro KwikPen: How Many Doses Are Inside?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The Mounjaro KwikPen is a branded tirzepatide delivery device that holds exactly four weekly doses—enough for one month of treatment. Unlike branded options that charge per dose, PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat, allowing your prescriber to adjust your strength as needed while keeping your cost predictable.

Understanding the Four-Dose Design of Mounjaro KwikPen

Each Mounjaro KwikPen device contains a pre-filled cartridge loaded with four individual doses of tirzepatide. The pen is engineered to deliver one full dose per week across a 28-day period, making it convenient for patients following a once-weekly injection schedule. After four weeks of use, the pen is fully depleted and a new one is required for the following month.

The tirzepatide molecule works by activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which together regulate appetite and blood sugar metabolism. This dual-receptor activation is why tirzepatide has demonstrated stronger weight loss results compared to single-agonist GLP-1 medications in clinical trials. The pen's design ensures consistent delivery of this active compound across all four weekly injections.

Tirzepatide Dose Escalation and Cost Considerations

Mounjaro KwikPens come in five different strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, and 15 mg per dose. Most prescribers begin patients at the lowest strength and increase every four weeks based on tolerance and weight loss response. Each strength tier requires purchasing a separate pen, which can increase out-of-pocket costs significantly as your dose climbs.

PlexusDx compounded tirzepatide injection operates on a different pricing model designed to remove this financial barrier. Your monthly cost remains flat at $289 regardless of whether your dose stays at 2.5 mg or increases to the higher therapeutic ranges. This approach means you can work with your prescriber to find your optimal dose without worrying about escalating pharmacy bills.

Compounded vs. Branded Tirzepatide: Key Differences

Branded Mounjaro comes from Eli Lilly and is manufactured through FDA-approved facilities using standardized processes. PlexusDx tirzepatide is compounded by licensed 503A compounding pharmacies, which means it is formulated in smaller batches using pharmaceutical-grade tirzepatide powder. Both deliver the same active molecule—tirzepatide—but the sourcing and manufacturing differ significantly.

The practical advantage of compounded tirzepatide extends beyond pricing. Because it is prepared by compounding pharmacies rather than pre-filled by a manufacturer, your prescriber has flexibility to adjust your strength or delivery method without requiring you to switch to a different branded pen. PlexusDx compounds both injectable and oral tirzepatide formulations, so you can explore the option that best fits your lifestyle.

Why Genetic Testing Matters for Tirzepatide Response

Not everyone responds identically to tirzepatide, and genetics play a measurable role in treatment outcomes. PlexusDx offers the Precision Peptide Genetic Test—a $99 add-on after your first month of treatment—that examines 14 metabolic pathways and 150+ genetic insights related to peptide response. Key variants like GLP1R rs6923761 and GIPR rs1800437 influence how your body utilizes tirzepatide signaling.

Understanding your genetic predispositions helps your PlexusDx prescriber tailor not only your tirzepatide dose but also decide whether a dual-compound option like GLP-Squared injection (tirzepatide plus semaglutide) might provide better results for your unique metabolism. This personalized approach transforms tirzepatide from a one-size-fits-all therapy into a precision treatment aligned with your biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections come in one Mounjaro KwikPen?

Each Mounjaro KwikPen contains four pre-filled doses intended for four weekly injections. PlexusDx compounded tirzepatide offers the same once-weekly dosing flexibility with flat monthly pricing of $289, allowing dose adjustments without cost increases.

What happens if I need to increase my tirzepatide dose?

If your prescriber recommends a dose increase, PlexusDx maintains your flat monthly cost of $289—your price won't change even as your dose strength does. This differs from branded Mounjaro, where each strength tier requires purchasing a separate pen at different price points.

Is PlexusDx tirzepatide the same as Mounjaro?

PlexusDx tirzepatide contains the identical active compound as Mounjaro but is compounded by licensed 503A pharmacies rather than manufactured by Eli Lilly. Both are effective tirzepatide products; PlexusDx offers predictable flat pricing and nationwide access without insurance requirements.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx Precision Peptide Genetic Test ($99 after month one) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence peptide pathway activation. These 150+ genetic insights help your prescriber optimize your tirzepatide dose and determine if dual-compound therapy would benefit you.

Why choose compounded tirzepatide over the brand name?

PlexusDx compounded tirzepatide injection delivers the same active medication at flat $289/month pricing, works in all 50 states without insurance, qualifies for HSA/FSA accounts, and pairs with genetic testing for personalized dosing. You avoid the cost escalation tied to branded dose increases.

Related Reading

• Mounjaro Doses
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.